£4.2M
The round was co-led by Oxford Science Enterprises and Cedars-Sinai to accelerate US expansion.
"We’ve spent the last two years proving that remote monitoring can transform neurological care. Clinicians are getting clearer insight without added workload, patients no longer face months of uncertainty between visits, and gain confidence that changes will be recognized rather than missed."